Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
BMC Cancer|February 7, 2020
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumorsCésar Serrano, Ana Vivancos, Antonio López-Pousa, et al.
Clinical Sarcoma Research|July 1, 2016
Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 studyJoan Maurel, Antonio López-Pousa, Silvia Calabuig, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
Cancers|October 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) GuidelinesMaria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez, et al.
Cancer Treatment Reviews|August 2, 2021
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part IIJavier Martínez-Trufero, Josefina Cruz Jurado, C Nieves Hernández-León, et al.
The Oncologist|August 22, 2018
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline ImatinibCésar Serrano, Xavier García-Del-Muro, Claudia Valverde, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic SarcomaJavier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge, et al.
Cancers|June 28, 2023
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)Rosa Álvarez Álvarez, Aránzazu Manzano, Carolina Agra Pujol, et al.
Pageof 7